PTX3 and disease arising from reactivation of latent virus: Further studies are needed to clarify the roles of different possible triggers for the increased PTX3 production, such as autoimmune inflammation, infections (including latent infection due to IRD-related dysregulation or immunosuppressive therapy), and atherogenic lipoproteins [12, 13, 38, 39].